RGCO:NASDAQRGC Resources Inc. Analysis
Data as of 2026-05-19 - not real-time
$22.89
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
RGC Resources is trading at $22.89, comfortably above its 20‑day and 50‑day SMAs, signaling a short‑term bullish bias despite a bearish MACD histogram and waning volume. Technical indicators show a neutral RSI (~51) and a bullish overall trend, while the stock’s beta of ~0.7 suggests limited market‑wide volatility, though 30‑day price swings remain high at over 50%.
Fundamentally, the company delivered a 14% earnings boost in Q2 2026, with EPS rising to $0.84 and revenue climbing 24.7% YoY. Valuation appears attractive: a trailing P/E of 17 versus an industry average of 21, and a dividend yield of 3.76% supported by a 62% payout ratio and positive free cash flow. However, the balance sheet is strained, featuring a debt‑to‑equity ratio above 118% and modest cash reserves, which tempers the upside potential.
Fundamentally, the company delivered a 14% earnings boost in Q2 2026, with EPS rising to $0.84 and revenue climbing 24.7% YoY. Valuation appears attractive: a trailing P/E of 17 versus an industry average of 21, and a dividend yield of 3.76% supported by a 62% payout ratio and positive free cash flow. However, the balance sheet is strained, featuring a debt‑to‑equity ratio above 118% and modest cash reserves, which tempers the upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages
- Bearish MACD signal and decreasing volume
- Strong dividend yield with sustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust revenue and earnings growth
- Undervalued relative to industry peers
- Attractive dividend yield reinforcing total return
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and debt‑service obligations
- Regulated utility model providing stable cash flow
- Long‑term dividend sustainability and modest growth outlook
Key Metrics & Analysis
Financial Health
Revenue Growth24.70%
Profit Margin13.01%
P/E Ratio17.1
ROE11.54%
ROA3.61%
Debt/Equity118.56
P/B Ratio2.0
Op. Cash Flow$23.6M
Free Cash Flow$2.2M
Industry P/E21.3
Technical Analysis
TrendBullish
RSI51.3
Support$21.20
Resistance$24.50
MA 20$22.79
MA 50$22.32
MA 200$21.95
MACDBearish
VolumeDecreasing
Fear & Greed Index89.41
Valuation
GradeUndervalued
TypeBlend
Dividend Yield3.76%
Risk Assessment
Beta0.70
Volatility52.13%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.